Impact of decreasing copayments on medication adherence within a disease management environment
Department of Quantitative Health Sciences
Adult; Aged; Anticholesteremic Agents; Cohort Studies; *Cost Sharing; Cross-Sectional Studies; Databases, Factual; *Disease Management; Female; Health Benefit Plans, Employee; Humans; Male; Middle Aged; Patient Compliance; United States
Biostatistics | Epidemiology | Health Services Research
This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a control employer that used the same DM program, adherence to medications in the value-based intervention increased for four of five medication classes, reducing nonadherence by 7-14 percent. The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs.
DOI of Published Version
Health Aff (Millwood). 2008 Jan-Feb;27(1):103-12. Link to article on publisher's site
Health affairs (Project Hope)
Chernew, Michael E.; Shah, Mayur R.; Wegh, Arnold; Rosenberg, Stephen N.; Juster, Iver A.; Rosen, Allison B.; Sokol, Michael C.; Yu-Isenberg, Kristina; and Fendrick, A. Mark, "Impact of decreasing copayments on medication adherence within a disease management environment" (2008). Quantitative Health Sciences Publications and Presentations. 926.